Skip to main content

Boehringer Ingelheim Press Releases

Quick access for journalists to the latest press releases that cover corporate, research & development, prescription, industrial, animal health and consumer pharmaceutical news.

Patients & Carers Health Care Professional in the US Health Care Professional outside the US Journalists Jobseekers

PRESS RELEASE 01 Sep 2016 at 15:00

Amgen obtains global development and commercial rights from Boehringer Ingelheim for investigational BiTE immuno-oncology drug for multiple myeloma

Read more
PRESS RELEASE 29 Aug 2016 at 08:30

Saniona and Boehringer Ingelheim sign collaboration agreement in schizophrenia

Read more
PRESS RELEASE 03 Aug 2016 at 10:00

Boehringer Ingelheim: Growth in all core businesses

Read more
PRESS RELEASE 21 Jul 2016 at 09:00

CZ Veterinaria and Boehringer Ingelheim Animal Health announce cooperation to bring innovative sow vaccine Entericolix® to the European market

Read more
PRESS RELEASE 20 Jul 2016 at 10:00

The European Stroke Organisation and Boehringer Ingelheim launch the “Angels Initiative”, a unique healthcare initiative to improve acute stroke care across Europe

Read more
PRESS RELEASE 14 Jul 2016 at 11:00

Boehringer Ingelheim and University of Dundee collaborate to develop new class of medicines

Read more
PRESS RELEASE 13 Jul 2016 at 14:00

Boehringer Ingelheim and Lilly Announce Clinical Trial Collaboration in Metastatic Breast Cancer

Read more
PRESS RELEASE 07 Jul 2016 at 15:00

Marina von Keyserlingk and Daniel Weary win first Ruminant Well-being Award

Read more
PRESS RELEASE 04 Jul 2016 at 13:00

Gaia Novarino wins Boehringer Ingelheim’s FENS Award 2016 for Exceptional Research in Neuroscience

Read more
PRESS RELEASE 27 Jun 2016 at 07:00

Sanofi and Boehringer Ingelheim have reached definitive agreements to swap Sanofi’s Animal Health and Boehringer Ingelheim’s Consumer Healthcare businesses

Read more
PRESS RELEASE 10 Jun 2016 at 13:00

Simone Menne – new Member of the Board of Managing Directors of Boehringer Ingelheim/Responsible for Corporate Board Division Finance

Read more
PRESS RELEASE 07 Jun 2016 at 16:00

Boehringer Ingelheim and Harvard scientists establish a research alliance to find novel treatments for severe fibrotic diseases

Read more
PRESS RELEASE 31 May 2016 at 10:00

Boehringer Ingelheim and Inventiva collaborate to develop potential new treatments for idiopathic pulmonary fibrosis

Read more
PRESS RELEASE 25 May 2016 at 09:00

Boehringer Ingelheim increases access to the medication for the treatment of HIV/Aids

Read more
PRESS RELEASE 24 May 2016 at 17:00

IL-23 inhibitor risankizumab induces remission in Phase II study in patients with moderate-to-severe Crohn’s disease

Read more
PRESS RELEASE 23 May 2016 at 10:00

Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented new treatment approaches for psychiatric diseases applying crowdsourcing

Read more
PRESS RELEASE 23 May 2016 at 08:45

Pooled data analysis of placebo-controlled trials confirms improvement in quality of life within 4 weeks of using oral bisacodyl/sodium picosulfate

Read more
PRESS RELEASE 11 May 2016 at 09:00

Nine out of 10 AF patients are concerned about stroke and many want to be part of OAC treatment decisions, new international survey shows

Read more
PRESS RELEASE 10 May 2016 at 14:00

New claim for use of Metacam^®20mg/ml in sheep simultaneously granted in Australia, Canada and New Zealand

Read more
PRESS RELEASE 21 Apr 2016 at 10:00

Boehringer Ingelheim initiates clinical evaluation of novel compound for chronic kidney disease

Read more